Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Gatlan vs Midi Health

Gatlan
Graded #389

Higher grade

vs+1.3999999999999986
Midi Health
Graded #414

Lower grade

The verdict

Gatlan takes it — 57.8/100 to 56.4/100, but only just.

Gatlan grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Gatlan is a telehealth platform offering compounded tirzepatide for weight management, positioned around "doctor-level care, minus the friction." Its standout feature is named clinical leadership — Chief… Midi Health is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
45
45
Dose & formulationEven
40
40
Clinical oversightGatlan +4
82
78
Labs & monitoringGatlan +10
62
52
FulfillmentMidi Health +8
70
78
Contract termsEven
55
55
Gatlan · left barMidi Health · right bar

The numbers

MetricGatlanMidi Health
WeighScore57.8/10056.4/100
GradeCC
Scorecard rank#389#414
SemaglutideNot disclosedNot disclosed
TirzepatideNot disclosedNot disclosed
Coverage44 statesAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Gatlan

Graded #389 · C

Strengths

  • Named Chief Medical Advisor with verifiable credentials — Dr. Robert Lufkin, UCLA/USC professor — rare in this market
  • 44 states explicitly listed — you can confirm coverage without starting the sign-up flow
  • 'Doctor-Level Care, Minus the Friction' positioning targets buyers wanting premium clinical attention
  • Fully online process with concierge delivery and monitoring
  • Compounded tirzepatide confirmed

Where it loses points

  • Pricing not shown publicly — fully gated behind the sign-up flow
  • Unclear whether compounded semaglutide is offered — only tirzepatide is mentioned on the site
  • LegitScript certification status not disclosed
  • 503A/503B pharmacy partner not named, and designation not specified
  • No compounded-medication disclaimer published
Midi Health

Graded #414 · C

Strengths

  • Available in all 50 states
  • Accepts commercial insurance — a differentiator vs cash-pay-only GLP-1 telehealth
  • Menopause + metabolic-health focus suits women where GLP-1 efficacy and weight regulation overlap most
  • Transparent self-pay visit fees ($250 initial, $150 follow-up); GLP-1 can also be billed through commercial insurance (copay + deductible)

Where it loses points

  • Does not accept Medicare, Medicaid, or Medi-Cal
  • GLP-1 is prescribed at clinician discretion within a menopause plan, not guaranteed at intake
  • Menopause-focused — not the right fit for men or younger women whose main goal is weight loss

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard